Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This study investigates whether there is a change in 123iodine-2ß-
carbomethoxy-3ß-(4-iodophenyl) tropane ([123I]ß-CIT) uptake after short-term treatment with
levodopa compared to either dopamine agonist or placebo.
Phase:
N/A
Details
Lead Sponsor:
Institute for Neurodegenerative Disorders
Collaborators:
GE Healthcare Pfizer
Treatments:
Cabergoline Carbidopa Carbidopa, levodopa drug combination Dopamine Levodopa